P557: LIFETIME CLINICAL OUTCOMES OF CPX-351 VERSUS 7 + 3 MODELED FROM THE 5-YEAR RESULTS OF A RANDOMIZED PHASE 3 TRIAL FOR OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK OR SECONDARY...

por Reifsnider, Odette, Yarnoff, Ben, Shoval, Hila, Fan, Lin
Publicado 2023

Tumor cells and their crosstalk with endothelial cells in 3D spheroids

por Shoval, Hila, Karsch-Bluman, Adi, Brill-Karniely, Yifat, Stern, Tal, Zamir, Gideon, Hubert, Ayala, Benny, Ofra
Publicado 2017

High mobility group box 1 antagonist limits metastatic seeding in the lungs via reduction of cell–cell adhesion

por Karsch-Bluman, Adi, Amoyav, Benzion, Friedman, Nethanel, Shoval, Hila, Schwob, Ouri, Ella, Ezra, Wald, Ori, Benny, Ofra
Publicado 2017